Efficacy and Safety Profile of Oral Tofacitinib in Non-Segmental Vitiligo
Soumya Jagadeesan, Neenu Prasad, Prasanna Duraiswamy, Vinitha Varghese Panicker · 2026
Read Efficacy and Safety Profile of Oral Tofacitinib in Non-Segmental Vitiligo by Soumya Jagadeesan, Neenu Prasad, Prasanna Duraiswamy, Vinitha Varghese Panicker (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13155714.txt.
Description
Soumya Jagadeesan, Neenu Prasad, Prasanna Duraiswamy, and Vinitha Varghese Panicker review in 2026 the results of a pill, tofacitinib, given to people with stubborn vitiligo. In vitiligo the immune system destroys the cells that color skin, and the attack runs through signals this drug can block.
The team looked back at sixteen patients, six men and ten women around forty years old, whose widespread vitiligo had resisted standard care. All took the pill alongside a skin cream and light therapy. The report weighs how much color returned and what side effects appeared, adding real-world evidence for a drug class gaining ground in skin medicine.
Catalog record
| CREATOR | Soumya Jagadeesan, Neenu Prasad, Prasanna Duraiswamy, Vinitha Varghese Panicker |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |